Richard I. Horowitz

527 total citations
16 papers, 336 citations indexed

About

Richard I. Horowitz is a scholar working on Parasitology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Richard I. Horowitz has authored 16 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Parasitology, 8 papers in Infectious Diseases and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Richard I. Horowitz's work include Vector-borne infectious diseases (11 papers), Viral Infections and Vectors (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Richard I. Horowitz is often cited by papers focused on Vector-borne infectious diseases (11 papers), Viral Infections and Vectors (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Richard I. Horowitz collaborates with scholars based in United States. Richard I. Horowitz's co-authors include Phyllis R. Freeman, Maryalice Citera, Qamar uz Zaman, Jyotsna Shah, Eva Sapi, Ranjan Ramasamy and John F. Fallon and has published in prestigious journals such as Journal of the American Geriatrics Society, Antibiotics and Microorganisms.

In The Last Decade

Richard I. Horowitz

15 papers receiving 319 citations

Peers

Countries citing papers authored by Richard I. Horowitz

Since Specialization

Citations

This map shows the geographic impact of Richard I. Horowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard I. Horowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard I. Horowitz more than expected).

Fields of papers citing papers by Richard I. Horowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard I. Horowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard I. Horowitz. The network helps show where Richard I. Horowitz may publish in the future.

Co-authorship network of co-authors of Richard I. Horowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Richard I. Horowitz. A scholar is included among the top collaborators of Richard I. Horowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard I. Horowitz. Richard I. Horowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome and Co-Infections, Including Bartonella: A Report of 3 Cases and a Literature Review 2024 ·Microorganisms ·Richard I. Horowitz, John F. Fallon, Phyllis R. Freeman	0
2	Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections 2023 ·Microorganisms ·Richard I. Horowitz, John F. Fallon, Phyllis R. Freeman	1
3	Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review 2022 ·Antibiotics ·Richard I. Horowitz, Phyllis R. Freeman	4
4	Effect of dapsone alone and in combination with intracellular antibiotics against the biofilm form of B. burgdorferi 2020 ·BMC Research Notes ·Richard I. Horowitz, (unknown), (unknown), Phyllis R. Freeman, Eva Sapi	8
5	A Fluorescence In Situ Hybridization (FISH) Test for Diagnosing Babesiosis 2020 ·Diagnostics ·Jyotsna Shah, (unknown), (unknown), (unknown), Richard I. Horowitz, (unknown), Ranjan Ramasamy	11
6	Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: A report of 2 cases 2020 ·Respiratory Medicine Case Reports ·Richard I. Horowitz, Phyllis R. Freeman, (unknown)	144
7	Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials 2020 ·Medical Hypotheses ·Richard I. Horowitz, Phyllis R. Freeman	51
8	Healthy Fetal Outcomes Using A Novel Treatment For Maternal Lyme Disease And Babesiosis During Consecutive Pregnancies: A Case Study and Literature Review 2020 ·Richard I. Horowitz, Phyllis R. Freeman	4
9	Combined Immunofluorescence (IFA) and Fluorescence In Situ Hybridization (FISH) Assays for Diagnosing Babesiosis in Patients from the USA, Europe and Australia 2020 ·Diagnostics ·Jyotsna Shah, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Richard I. Horowitz, (unknown), Ranjan Ramasamy	4
10	Efficacy of Double-Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-infections: A Report of Three Cases and Retrospective Chart Review 2020 ·Antibiotics ·Richard I. Horowitz, Phyllis R. Freeman	10
11	<p>Precision medicine: retrospective chart review and data analysis of 200 patients on dapsone combination therapy for chronic Lyme disease/post-treatment Lyme disease syndrome: part 1</p> 2019 ·International Journal of General Medicine ·Richard I. Horowitz, Phyllis R. Freeman	23
12	Precision Medicine: The Role of the MSIDS Model in Defining, Diagnosing, and Treating Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome and Other Chronic Illness: Part 2 2018 ·Healthcare ·Richard I. Horowitz, Phyllis R. Freeman	21
13	Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report 2018 ·Clinical Case Reports ·Richard I. Horowitz, Phyllis R. Freeman	4
14	Empirical validation of the Horowitz Multiple Systemic Infectious Disease Syndrome Questionnaire for suspected Lyme disease 2017 ·International Journal of General Medicine ·Maryalice Citera, Phyllis R. Freeman, Richard I. Horowitz	31
15	The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome 2016 ·Journal of Clinical & Experimental Dermatology Research ·Richard I. Horowitz	13
16	Left Atrial Myxoma in the Elderly 1986 ·Journal of the American Geriatrics Society ·(unknown), (unknown), Qamar uz Zaman, Richard I. Horowitz	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact